Identification |
Name: | Hexanamide,N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]- |
Synonyms: | Hexanamide,N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]- (9CI); Hexanamide,N-[2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-, [R-[R*,S*-(E)]]-; C6-Ceramide;D-erythro-C6-Ceramide; N-Caproyl-C18-sphingosine;N-Hexanoyl-D-erythro-sphingosine; N-Hexanoylsphingosine |
CAS: | 124753-97-5 |
Molecular Formula: | C24H47 N O3 |
Molecular Weight: | 397.63 |
InChI: | InChI=1/C24H47NO3/c1-3-5-7-8-9-10-11-12-13-14-15-16-18-19-23(27)22(21-26)25-24(28)20-17-6-4-2/h18-19,22-23,26-27H,3-17,20-21H2,1-2H3,(H,25,28) |
Molecular Structure: |
|
Properties |
Flash Point: | 301.4°C |
Boiling Point: | 574.7°C at 760 mmHg |
Density: | 0.946g/cm3 |
Refractive index: | 1.482 |
Flash Point: | 301.4°C |
Storage Temperature: | −20°C |
Usage: | A biologically active, cell permeable, but nonphysiologic ceramide analog. It stimulates protein phosphatase 2A at concentrations as low as 10 nM and activiates MAP kinase. It induces apoptosis and inhibits glycoproptein traffic by the secretory p |
Safety Data |
|
|